Learn more about whether Bausch + Lomb Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

Vascular diseases, including aneurysms, arterial blockages, and deep vein thrombosis, can be life-threatening if untreated.

A local vascular surgeon has highlighted a simple injection that could alleviate leg pain for those experiencing heaviness or ...

An Abbott-funded report, written by leading vascular experts from the NHS, found that the health service could save more than ...

After years of decreasing amputations in the United States, rates of non-traumatic lower extremity amputations due to ...

The hospital's state-of-the-art American Heart and Vascular Institute performed a challenging surgery including open ...

After years of decreasing amputations in the United States, rates of non-traumatic lower extremity amputations due to diabetes and related conditions are rising, and Oklahoma is among the states with ...

February is American Heart Month, a time to focus on cardiovascular health, particularly conditions that often go unnoticed until it’s too late: Peripheral Artery Disease, or PAD. PAD affects 10 ...

Health First’s Heart & Vascular Program has earned its third straight 3-star overall isolated Coronary Artery Bypass Graft (CABG) recognition from the Society of Thoracic Surgeons (STS). [...] ...

Learn more about whether LeMaitre Vascular, Inc. or Envista Holdings Corporation is a better investment based on AAII's A+ ...